These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29225856)

  • 61. [Drug-induced immune hemolytic anemia caused by cefmetazole].
    Shioji N; Mizutani M; Okayama M; Katayama H; Ooya E; Sekine T; Masuya M
    Rinsho Ketsueki; 2018; 59(7):884-888. PubMed ID: 30078798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.
    Finsterer J; Kotzailias N
    Platelets; 2003 Aug; 14(5):329-31. PubMed ID: 12944250
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
    Dietrich ES; Schubert B; Ebner W; Daschner F
    Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review.
    Petersen MW; Perner A; Sjövall F; Jonsson AB; Steensen M; Andersen JS; Achiam MP; Frimodt-Møller N; Møller MH
    Acta Anaesthesiol Scand; 2019 Aug; 63(7):973-978. PubMed ID: 31020663
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Piperacillin-tazobactam drug-induced immune haemolysis in a case of paroxysmal nocturnal haemoglobinuria.
    McDonald L; Brodie R; Murphy K; Wright P; Webster R; Fitzgerald J
    Transfus Med; 2019 Apr; 29(2):138-140. PubMed ID: 30916843
    [No Abstract]   [Full Text] [Related]  

  • 68. Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia.
    Karino F; Miura K; Fuchita H; Koba N; Nishikawa E; Hotta T; Okimoto T; Iwamoto S; Tsubata Y; Tada M; Hamaguchi S; Honda T; Ohe M; Sutani A; Kuraki T; Takeyama H; Isobe T
    J Infect Chemother; 2013 Oct; 19(5):909-15. PubMed ID: 23645226
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.
    Kauf TL; Prabhu VS; Medic G; Borse RH; Miller B; Gaultney J; Sen SS; Basu A
    BMC Infect Dis; 2017 Apr; 17(1):314. PubMed ID: 28454524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
    Kuti JL; Nightingale CH; Quintiliani R; Nicolau D
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):51-7. PubMed ID: 12376031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetic characteristics of piperacillin/tazobactam.
    Sörgel F; Kinzig M
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S14-20. PubMed ID: 7962984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.
    Thibault C; Lavigne J; Litalien C; Kassir N; Théorêt Y; Autmizguine J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Gniadek TJ; Arndt PA; Leger RM; Zydowicz D; Cheng EY; Zantek ND
    Transfusion; 2018 Jan; 58(1):181-188. PubMed ID: 28990203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients.
    Zander J; Döbbeler G; Nagel D; Scharf C; Huseyn-Zada M; Jung J; Frey L; Vogeser M; Zoller M
    Int J Antimicrob Agents; 2016 Oct; 48(4):435-9. PubMed ID: 27476810
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Piperacillin/tazobactam-induced paresthesiae.
    Lambourne J; Kitchen J; Hughes C; Merry C
    Ann Pharmacother; 2006 May; 40(5):977-9. PubMed ID: 16622157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serological studies of piperacillin antibodies.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2008 Nov; 48(11):2429-34. PubMed ID: 18657075
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
    Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
    Sanders CV
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S21-6. PubMed ID: 7962985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
    Kuye O; Teal J; DeVries VG; Morrow CA; Tally FP
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():113-24. PubMed ID: 8383652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.